Skip to content
Join our Newsletter

Technology

One of 2020’s biggest games taps the brains (and jaw and lips) of B.C. researcher

One of 2020’s biggest games taps the brains (and jaw and lips) of B.C. researcher

Tech developed in part by SFU professor now featured in Cyberpunk 2077
Securities regulator grapples with fintech innovations

Securities regulator grapples with fintech innovations

Complications arise when new finance technology meets current securities regulations
How vaccine distribution is taking shape amid manufacturing hiccups, remote deliveries

How vaccine distribution is taking shape amid manufacturing hiccups, remote deliveries

Ottawa says Canada still set to receive four million doses by March even as Pfizer faces production issues
Rogers rolls out first 5G standalone core in Vancouver, expands B.C. coverage

Rogers rolls out first 5G standalone core in Vancouver, expands B.C. coverage

Rogers Communications Inc. (TSX:RCI.B) is rolling out the first 5G standalone core in Canada, with Vancouver among four cities that will be able to eventually tap into the new infrastructure.
From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout

From keeping cool to prioritizing people, how B.C. businesses are supporting vaccine rollout

B.C. companies are stepping up to assist with the rollout of the vaccine
AbCellera’s market value hits US$15.7b after first day of trading

AbCellera’s market value hits US$15.7b after first day of trading

Vancouver biotech known for its work on a COVID-19 treatment
Beware – Santa could bring home cybersecurity risks

Beware – Santa could bring home cybersecurity risks

Proliferation of home high-tech gadgets could expose personal data to crooks
AbCellera IPO: Shares surge more than 250% upon debut (UPDATED)

AbCellera IPO: Shares surge more than 250% upon debut (UPDATED)

Trading held at the opening of markets
AbCellera boosts IPO target second time in a week, seeks to raise US$483m

AbCellera boosts IPO target second time in a week, seeks to raise US$483m

The B.C. biotech firm instrumental in the development of a COVID-19 treatment has boosted its ambitions for an initial public offering for the second time in a week. AbCellera Biologics Inc.
Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others

Boast.AI raises $30m as B.C. tech firm hones in on R&D tax credits for others

Vancouver company plans to boost its headcount following close of Series A funding round